Chlamydia Testing: A Complete Guide to Screening, Timing, and Results

Key takeaways

• Chlamydia testing is recommended at least annually for sexually active women under 25 and for older women with risk factors, and for men who have sex with men at sites of exposure.
• Nucleic acid amplification tests (NAATs) are the preferred method and can be performed on a first-catch urine sample or a swab from the vagina, cervix, urethra, rectum, or throat.
• Many chlamydia infections produce no symptoms, so a person can be infected and transmit the bacteria without knowing it.
• Chlamydia is curable with antibiotics, and retesting about three months after treatment is recommended for people who test positive.

What Chlamydia Testing Detects

Chlamydia testing looks for evidence of the bacterium Chlamydia trachomatis in a sample from a body site where the infection may be present. The most common and most sensitive tests are nucleic acid amplification tests, often called NAATs, which detect the organism's genetic material rather than waiting for bacteria to grow in culture. NAATs can be run on urine or on swabs taken from the vagina, cervix, urethra, rectum, or throat.

Testing is different from diagnosis by symptoms alone. Because chlamydia often causes no noticeable signs, a person may feel completely well and still have an infection. Laboratory testing is therefore the only way to confirm or rule out chlamydia, and it also helps distinguish it from other infections such as gonorrhea, which can produce similar symptoms and may occur at the same time.

Who Should Be Screened and How Often

Screening recommendations focus on people at higher risk rather than everyone. National guidance generally advises annual chlamydia screening for sexually active women aged 25 and younger, and for older women who have risk factors such as a new sex partner, more than one partner, a partner with an STI, or inconsistent condom use. Pregnant women are often screened early in pregnancy because treatment protects both the pregnant person and the newborn.

For men who have sex with men, testing is typically recommended at least annually, with extra testing at sites of exposure such as the rectum or throat. Sexually active men who have sex with women may be tested when they have symptoms or when a partner has been diagnosed. Because recommendations can change and depend on individual circumstances, a clinician can tailor the schedule to a person's situation.

How Samples Are Collected

Sample collection depends on the test and the site being checked. A first-catch urine sample is common and simple: the person urinates into a cup, ideally after not urinating for about one to two hours, because a concentrated sample improves detection. For women, a vaginal swab can often be self-collected in a clinic or at home, and it is as reliable as a clinician-collected cervical swab for NAAT testing.

Swabs may also be taken from the cervix, urethra, rectum, or throat when those sites need evaluation. Some clinics offer self-collection kits for use at home, which are then mailed to a laboratory. Results are usually available within a few days, though turnaround times vary by laboratory and test type.

Understanding Results and Next Steps

A negative result generally means the test did not detect Chlamydia trachomatis in the sample provided. However, a negative result does not rule out infection if the sample was collected too soon after exposure, because it can take one to two weeks or more for an infection to become detectable. A positive result means the bacterium was found, and chlamydia is treatable with prescription antibiotics. It is important to take the full course exactly as directed and to avoid sex until treatment is completed and any follow-up instructions are met.

People who test positive are usually advised to notify recent sexual partners so they can be tested and treated, which helps prevent reinfection. Retesting about three months after treatment is commonly recommended because reinfection is possible, especially if a partner was not treated. A clinician can explain whether additional testing for other STIs is appropriate at the same visit.

Frequently Asked Questions

Sources

• CDC: Chlamydia – CDC Basic Fact Sheet
• CDC: Chlamydia Screening Recommendations
• MedlinePlus: Chlamydia Infections
• Mayo Clinic: Chlamydia trachomatis – Diagnosis and Treatment
• NIH: Chlamydia – Sexually Transmitted Infections